ICU · Cardiovascular
Acute decompensated heart failure: NIV, diuretics, inotropes, and MCS in ICU
Also known as ADHF · Acute heart failure · Cardiogenic pulmonary oedema · Flash pulmonary oedema · Acute decompensated HF
Acute decompensated heart failure (ADHF) = sudden worsening of heart failure → pulmonary oedema and/or systemic congestion. PRECIPITANTS: ACS, arrhythmia (AF), infection, non-adherence (medications/diet), renal failure, anaemia, thyroid, drugs (NSAIDs, calcium channel blockers). CLASSIFICATION: (1) 'WARM AND WET' (most common — pulmonary oedema + preserved perfusion — BP normal/high) → vasodilators + diuretics. (2) 'COLD AND WET' (cardiogenic shock — hypoperfusion + congestion — hypotensive) → inotropes + diuretics ± MCS. (3) 'WARM AND DRY' (compensated). (4) 'COLD AND DRY' (low output, no congestion). MANAGEMENT: (1) NIV (CPAP/BiPAP — 3CPO trial — faster relief of dyspnoea and metabolic disturbance; no difference between CPAP and BiPAP; no effect on short-term mortality). (2) DIURETICS (frusemide IV — 1-2.5x usual oral dose — DOSE trial: high vs low dose — no difference in symptoms or renal function; continuous vs bolus — no difference). (3) VASODILATORS (nitroglycerin for the hypertensive congested patient — reduce preload/afterload). (4) INOTROPES (if cold — dobutamine, milrinone — bridge only: PROMISE and OPTIME-CHF). (5) MCS (IABP, Impella, VA-ECMO — if refractory shock — IABP-SHOCK II: no routine IABP). (6) IDENTIFY + TREAT PRECIPITANT (ACS → PCI; AF → cardioversion; infection → antibiotics). AVOID: beta-blockers acutely (negative inotrope — may worsen), calcium channel blockers (negative inotrope), NSAIDs (sodium retention), routine morphine (ADHERE: associated with worse outcomes), routine ultrafiltration (CARRESS-HF). INITIATE GDMT (four pillars) once stabilised (MERIT-HF, CIBIS-II, COPERNICUS).
Checked against its sources on 11 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- NIV (CPAP/BiPAP) EARLY — faster relief of dyspnoea and metabolic disturbance (3CPO)
- 'Cold and wet' = cardiogenic shock → inotropes + consider MCS
- DOSE trial: high vs low frusemide — no outcome difference
- AVOID beta-blockers, CCBs, NSAIDs acutely (negative inotrope/sodium retention)
- Identify + treat precipitant (ACS, AF, infection, non-adherence)
- Initiate GDMT four pillars once stabilised
Meet the patient
A 72-year-old man with known HFrEF arrives at 3am sat bolt upright, gasping, coughing pink froth, saturating 84 per cent on room air. His BP is 168/96, he is in fast atrial fibrillation at 122, crackles reach the apices, and his JVP is raised — but his peripheries are warm. He ran out of his bisoprolol, ramipril, spironolactone and dapagliflozin five days ago. The two questions that decide his next hour are the two that decide every ADHF: is he warm or cold? (that splits diuretic-and-vasodilator from inotrope) and what tipped him over? (a trigger you must find and fix before he leaves). Hold those two questions and the whole algorithm slots into place.[4]
References24ShowHide
- [1]Gray A, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. The New England journal of medicine, 2008.PMID 18614781
- [2]Felker GM, et al. Diuretic strategies in patients with acute decompensated heart failure. The New England journal of medicine, 2011.PMID 21366472
- [3]Bart BA, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. The New England journal of medicine, 2012.PMID 23131078
- [4]Ponikowski P, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal, 2016.PMID 27206819
- [5]Mebazaa A, et al. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive care medicine, 2016.PMID 26370690
- [6]Nohria A, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. Journal of the American College of Cardiology, 2003.PMID 12767667
- [7]Costanzo MR, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Journal of the American College of Cardiology, 2007.PMID 17291932
- [8]Chen HH, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA, 2013.PMID 24247300
- [9]De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock. The New England journal of medicine, 2010.PMID 20200382
- [10]Thiele H, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. The New England journal of medicine, 2012.PMID 22920912
- [11]Peacock WF, et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emergency medicine journal : EMJ, 2008.PMID 18356349
- [12]MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet (London, England), 1999.PMID 10376614
- [13]CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet (London, England), 1999.PMID 10023943
- [14]Packer M, et al. Effect of carvedilol on survival in severe chronic heart failure. The New England journal of medicine, 2001.PMID 11386263
- [15]Packer M, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. The New England journal of medicine, 1991.PMID 1944425
- [16]Cuffe MS, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA, 2002.PMID 11911756
- [17]Houseman BS, et al. High-dose nitroglycerin infusion description of safety and efficacy in sympathetic crashing acute pulmonary edema: The HI-DOSE SCAPE study. The American journal of emergency medicine, 2023.PMID 36327753
- [18]Collins S, et al. Optimizing Hypertensive Acute Heart Failure Management with Afterload Reduction. Current hypertension reports, 2018.PMID 29478124
- [19]Palazzuoli A, et al. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF. ESC heart failure, 2017.PMID 28980452
- [20]DeAngelo S, et al. Predictors and Trends of 30-day Readmissions in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insight From the National Readmission Database. International journal of heart failure, 2025.PMID 39911571
- [21]Shah D, et al. Mechanical Circulatory Support in Cardiogenic Shock: A Narrative Review. Cureus, 2024.PMID 39411633
- [22]Zafrir B, et al. Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives. The Israel Medical Association journal : IMAJ, 2012.PMID 22675861
- [23]Martens P, et al. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial. Circulation, 2023.PMID 36335479
- [24]Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2022.PMID 35379503